Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) – Stock analysts at SunTrust Banks dropped their Q3 2017 earnings estimates for shares of Allscripts Healthcare Solutions in a research note issued on Monday. SunTrust Banks analyst S. Draper now anticipates that the software maker will earn $0.11 per share for the quarter, down from their prior forecast of $0.12. SunTrust Banks also issued estimates for Allscripts Healthcare Solutions’ Q4 2017 earnings at $0.15 EPS, FY2017 earnings at $0.45 EPS and FY2018 earnings at $0.59 EPS.

Other analysts have also recently issued reports about the company. Maxim Group reiterated a “buy” rating and issued a $16.00 price target on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Cantor Fitzgerald reiterated a “buy” rating and issued a $17.00 price target (up from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Monday. Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Piper Jaffray Companies reiterated a “hold” rating and issued a $14.00 price target on shares of Allscripts Healthcare Solutions in a research report on Friday, July 21st. Finally, BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Saturday, June 24th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and an average price target of $14.59.

WARNING: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/08/17/suntrust-banks-brokers-lower-earnings-estimates-for-allscripts-healthcare-solutions-inc-mdrx.html.

Allscripts Healthcare Solutions (NASDAQ MDRX) opened at 13.00 on Thursday. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $13.70. The stock’s 50 day moving average is $12.51 and its 200 day moving average is $12.20. The firm’s market cap is $2.35 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The firm had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. During the same period last year, the firm posted $0.14 EPS. The business’s revenue was up 10.2% compared to the same quarter last year.

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Allscripts Healthcare Solutions by 1.2% in the second quarter. Vanguard Group Inc. now owns 14,824,640 shares of the software maker’s stock valued at $189,162,000 after buying an additional 181,721 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Allscripts Healthcare Solutions by 26.9% in the second quarter. Dimensional Fund Advisors LP now owns 9,171,285 shares of the software maker’s stock valued at $117,026,000 after buying an additional 1,943,496 shares in the last quarter. Fiduciary Management Inc. WI boosted its position in Allscripts Healthcare Solutions by 0.6% in the second quarter. Fiduciary Management Inc. WI now owns 6,083,536 shares of the software maker’s stock valued at $77,626,000 after buying an additional 38,426 shares in the last quarter. State Street Corp boosted its position in Allscripts Healthcare Solutions by 28.6% in the second quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock valued at $76,251,000 after buying an additional 1,330,721 shares in the last quarter. Finally, First Trust Advisors LP boosted its position in Allscripts Healthcare Solutions by 48.0% in the first quarter. First Trust Advisors LP now owns 5,855,944 shares of the software maker’s stock valued at $74,253,000 after buying an additional 1,898,007 shares in the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.